TMCnet News
Tauriga Sciences Inc. Reveals Several of the Specific & Differentiating Features Integrated into its Cannabis/CBD Infused Chewing Gum Product LineNew York, NY, Jan. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, has today revealed several of the specific & differentiating features integrated into its Cannabis/CBD chewing gum product line (“CBD Gum”). In a recent press release, the Company mentioned that it had conceived its CBD Gum product line, by implementing the advice that several prospective distributors had recommended to management. Integrated into Tauriga’s CBD Gum Product line, are the following specifically integrated features:
In other news, the Company has selected the following name under to which to brand its CBD Gum product line: Tauri-GUM. Several weeks ago, the Company confirmed that it had applied for (“filed for”) this above-referenced trademark with the United States Patent & Trademark Office (“U.S.P.T.O.”); the Company’s Trademark Application has been assigned the serial # 88/226,543. The Company has also been focused on the creation of its Logo (Tauri-Gum brand) and the completion of the artwork and graphic design(s) for both the outer product package (individual pack) as well as the display cases (for retail locations). Once this creative work has been completed, the Company will disclose its Logo and graphic design artwork to its shareholders (through a press release).
Studies have shown that a chewing gum product may provide a superior delivery method for distributing its key active ingredients (such as CBD), in comparison to other oral dosage forms, such as: pills, capsules, beverages, and gummies. As an individual chews gum, the CBD is released from the gum quickly and is absorbed by the Oral Mucosa, rather than the Digestive System. Bypassing the Digestive Tract allows the CBD to maintain its inherent bioavailability, and it also means that the CBD gets absorbed by the body – substantially faster than other forms of Oral Ingestion. Studies have also shown that CBD that is swallowed as capsules, beverages, gummies or edibles delivers less than 10% of the CBD shown on each respective label. With CBD Infused Chewing Gum, an individual can get relief for aches and pains in rapid time, and at a dose that is potentially strong enough to make a noticeable difference, and delivered cost effectively without wasting the majority of the CBD consumed. Tauriga Sciences, Inc. (TAUG) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities/equity investments. The Company is currently evaluating potential acquisition candidates, as previously disclosed, to create lasting shareholder value. Additionally, the Company is working diligently to identify potential opportunities to generate revenue and leverage its considerable resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com Forward-Looking Statements Contact: CONTACT INFORMATION Tauriga Sciences, Inc. 555 Madison Avenue, 5th Floor New York, NY 10022 Chief Executive Officer Mr. Seth M. Shaw Email: [email protected] cell # (917) 796 9926 www.tauriga.com |